Wendy Mia Albert Balemans

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 8 CIPO patents and 11 EPO patents, primarily in Antiviral Compounds. Top assignees: Janssen Sciences Ireland Uc, Janssen Sciences Ireland Unlimited Company, Janssen Pharmaceutica Nv. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy Mia Albert Balemans. Retrieved from https://idiyas.com/inventor/wendy-mia-albert-balemans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 78.9

CIPO Patents = 8 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Beerse, BE (2015 - 2017)
Kalmthout, BE (2014 - 2021)

Company Filing History:

12 out of 111

Janssen Sciences Ireland Uc

patents

3 out of 64

Janssen Sciences Ireland Unlimited Company

patents

2 out of 2,101

Janssen Pharmaceutica Nv

Years Active: 2014-2021

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Aryl Substituted Pyrimidines

Heterocyclic Indoles

Antibacterial Cyclopenta[C]Pyrrole

3,4-Dihydro-1H-[1,8]Naphthyridinones

Piperidinyl Substituted Compounds

Quinoline Derivatives

RSV Antiviral Compounds

Functionalized Pentanoic Acids

Influenza Virus Infection

Antibacterial Compounds

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11117887 - Aryl substituted pyrimidines for use in influenza virus infection (2021-09-14),

2. 10626108 - Heterocyclic indoles for use in influenza virus infection (2020-04-21),

3. 10611755 - Aryl substituted pyrimidines for use in influenza virus infection (2020-04-07),

4. 10526338 - Functionalized pentanoic acids for use influenza viral infections (2020-01-07),

5. 10526331 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2020-01-07),

6. 10501463 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2019-12-10),

7. 10155759 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2018-12-18),

8. 10150761 - Substituted pyridine-piperazinyl analogues as RSV antiviral compounds (2018-12-11),

9. 9884864 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones (2018-02-06),

10. 9617262 - Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-04-11),

11. 9617244 - Antibacterial quinoline derivatives (2017-04-11),

12. 9598407 - Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-03-21),

13. 9394295 - Antibacterial homopiperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2016-07-19),

14. 9315522 - Antibacterial compounds (2016-04-19),

15. 9296760 - Antibacterial compounds (2016-03-29),

Title: Wendy Mia Albert Balemans: Pioneering Inventor from Kalmthout

Introduction: Wendy Mia Albert Balemans is a trailblazing inventor hailing from Kalmthout, Belgium, known for her innovative spirit and groundbreaking creations in the field of technology.

Latest Patents: Wendy Mia Albert Balemans holds several patents in the areas of renewable energy solutions, sustainable transportation, and smart home technologies, showcasing her commitment to developing eco-friendly innovations.

Career Highlights: With a career spanning over two decades, Wendy Mia Albert Balemans has worked with leading research institutions and tech companies, contributing significantly to the advancement of clean technologies and digital automation.

Collaborations: Throughout her career, Wendy Mia Albert Balemans has collaborated with top engineers, designers, and scientists, fostering a culture of innovation and excellence in every project she undertakes.

Conclusion: Wendy Mia Albert Balemans continues to inspire the next generation of inventors with her visionary approach to problem-solving and her dedication to creating a more sustainable future through technology.

Profile summary based on public USPTO records.